Trials / Completed
CompletedNCT00380705
Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
Quality of Life in Asthma and Rhinitis Allergic With Singulair
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 91 (estimated)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
Allow physicians not familiar with anti-leukotriene based therapy to test it
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 Weeks |
Timeline
- Start date
- 2005-03-18
- Primary completion
- 2005-07-29
- Completion
- 2005-07-29
- First posted
- 2006-09-26
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00380705. Inclusion in this directory is not an endorsement.